AUSTRALIA · TENDER
Antithrombin III Procurement
Antithrombin III Procurement The National Blood Authority (NBA) is inviting tenders for the provision of an Antithrombin III product. This procurement aims to establish new Deed arrangements by 1 June 2027, following the current supply arrangements for Thrombotrol under the National Fractionation Agreement for Australia (NaFAA). Scope of Work The successful…
Decide whether this tender fits your team
Your team keeps the bid/no-bid decision.
Request a bid/no-bid review · Search related open tenders
Confirm the actual work location in the procurement documents.
Key facts
- Buyer
- Buyer not disclosed
- Buyer address
- ACT, NSW, VIC, SA, WA, QLD, NT, TAS
- Status
- Open
- Opened
- 30 Sept 2026
- Closing
- 20 Nov 2026
- Categories
- Drugs and Pharmaceutical Products
Summary and scope
The NBA invites Tenders for the provision of an Antithrombin III product. The NBA currently has arrangements in place for the supply of Thrombotrol under the National Fractionation Agreement for Australia (NaFAA). Additional information is set out within the RFT document.
Source and freshness
Source data updated 10 Nov 2026
Information shown is sourced from public opportunity records. Official buyer documents and addenda take precedence for deadlines, eligibility and submission requirements.